News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Risk of death 54 percent lower with remdesivir added for hospitalized COVID-19 patients on O₂ support
01 Jul 2024
byMike Ng
The inclusion of remdesivir in the SoC is significantly associated with a 54-percent lower risk of death at day 28 among hospitalized adults with COVID-19 who require O2 support, suggests a cross-study comparison that weight-balances patients from a clinical trial with those from a real-world study
01 Jul 2024

Pioglitazone boosts HbA1c decrease while preventing ketone increase
29 Jun 2024
byStephen Padilla
In patients with type 1 diabetes (T1D) treated with SGLT2 inhibitors, such as dapagliflozin, the addition of pioglitazone helps to intensify the reduction in HbA1c and blocks the increase in plasma ketone driven by SGLT2 inhibitors, reports a study presented at ADA 2024. This enables long-term cardiovascular and renal outcome studies to be safely performed in T1D patients.
29 Jun 2024






